Skip to main content
Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
83.25
+1.61 (1.97%)
Mar 9, 2026, 3:03 PM EDT - Market open

Edwards Lifesciences Revenue

In the year 2025, Edwards Lifesciences had annual revenue of $6.07B with 11.55% growth. Edwards Lifesciences had revenue of $1.57B in the quarter ending December 31, 2025, with 13.26% growth.

Revenue (ttm)
$6.07B
Revenue Growth
+11.55%
P/S Ratio
7.85
Revenue / Employee
$379,225
Employees
16,000
Market Cap
48.35B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20256.07B628.10M11.55%
Dec 31, 20245.44B429.50M8.57%
Dec 31, 20235.01B546.00M12.23%
Dec 31, 20224.46B-768.50M-14.69%
Dec 31, 20215.23B846.20M19.29%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Medtronic 35.48B
Stryker 25.12B
Koninklijke Philips 20.94B
GE HealthCare Technologies 20.63B
Boston Scientific 20.07B
Zimmer Biomet Holdings 8.23B
Smith & Nephew 6.16B
STERIS 5.83B
Revenue Rankings

EW News

More News